Akoya Biosciences
(NASDAQ) AKYA
This security has been delisted. This page is retained for historical reference.
AKYA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAKYA Financials
Key Financial Metrics (TTM)
Gross Margin
64%
Operating Margin
-50%
Net Income Margin
-63%
Return on Equity
-28%
Return on Capital
-4%
Return on Assets
-21%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$47.88M
Operating Income
$46.73M
EBITDA
$37.14M
Operating Cash Flow
$44.10M
Capital Expenditure
$2.46M
Free Cash Flow
$46.56M
Cash & ST Invst.
$35.04M
Total Debt
$84.15M
Akoya Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$16.64M
-9.3%
Gross Profit
$9.87M
+17.8%
Gross Margin
59.32%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
205
N/A
Net Income
$15.65M
+33.4%
EBITDA
$11.31M
+39.7%
Quarterly Fundamentals
Net Cash
$56.18M
-137.9%
Accounts Receivable
$11.74M
-12.8%
Inventory
$22.85M
-0.6%
Long Term Debt
$4.02M
-95.1%
Short Term Debt
$79.70M
+1081.8%
Return on Assets
-21.17%
N/A
Return on Invested Capital
-4.19%
N/A
Free Cash Flow
$7.42M
+65.7%
Operating Cash Flow
$7.21M
+65.4%